Radiolabeling and In-Silico Study of 131I-(4-Fluorobenzoyl-3-Methylthiourea) As Radiopharmaceuticals for Breast Cancer Theranostics. Valensi 2024, 10 (1), 27-44. https://doi.org/10.15408/jkv.v10i1.34258.